Introduction Therapies that target activating Egfr, Alk, Ros1 and other mutations have become
first-line treatments that improve NSCLC patient’s life expectancy. Latin-American patients …

About 4% to 7% of the non–small-cell lung cancer patients have anaplastic lymphoma
kinase (ALK) rearrangements, and specific targeted therapies improve patients' outcomes …

Abnormal tau accumulations were observed and documented in post‐mortem brains of
patients affected by Alzheimer's disease ( AD ) long before the identification of mutations in the …

Operating shared resource laboratories (SRLs) in times of pandemic is a challenge for
research institutions. In a multiuser, high‐turnover working space, the transmission of infectious …

… on Germany. Most of the data used in this study are showing the responses from German …
of the art in Germany, with 12% of the data coming from non- German Hospitals. Extraoral …

The molecular organization of presynaptic active zones during calcium influx–triggered
neurotransmitter release is the focus of intense investigation. The Drosophila coiled-coil domain …

… of German national identity, this debate was directly related to the definition of Germany’s …
in movie history, both as one of the first German sound films and as an example of the use of …

Motivation: Life prospects of non-small cell lung cancer (NSCLC) patients have greatly
improved over the last decades with the adoption of tumor genomic profiling. A better …

… Many members are drawn from well-established national and international networks,
including but not limited to German BioImaging (GerBI), Microscopie de Fluorescence …

Mortalin is an essential component of the molecular machinery that imports nuclear-encoded
proteins into mitochondria, assists in their folding, and protects against damage upon …